Delivery Order SPE2DB25D3504-SPE2DB25FVWBK
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $21,362.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing pharmaceutical supply framework with DLA. Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist primarily used in the treatment of chronic...
- The Defense Logistics Agency awarded a delivery order valued at $2,641.03 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) on July 24, 2025, with completion expected by July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of KERENDIA 10 mg tablets (30-count units) under a firm fixed-price contract valued at $3,772.69. This non-set-aside competitive award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,324.97 for Kerendia 10 mg tablets (90-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing pharmaceutical...
- The Defense Logistics Agency awarded a $3,669.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 MG tablets (30-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a small-value pharmaceutical delivery executed through AmerisourceBergen's existing indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.08 to AmerisourceBergen Drug Corp for KERENDIA 20 MG tablets (30-count package) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,593.24 on August 20, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease, representing the type of...
- The Defense Logistics Agency awarded a $2.27K delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count units) on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed-price, non-set-aside contract represents a direct award under competitive procurement procedures and will be performed at the contractor's Conshohocken, Pennsylvania facility. Kerendia is a prescription medication used in the treatment of chronic kidney disease, reflecting...
- The Defense Logistics Agency awarded a $2,687.81 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Kerendia 10 mg, a pharmaceutical product used in the treatment of chronic kidney disease. This competitively awarded, firm fixed-price contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,760.59 and an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Kerendia is a brand-name pharmaceutical...